1. Home
  2. MDAI vs DMA Comparison

MDAI vs DMA Comparison

Compare MDAI & DMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • DMA
  • Stock Information
  • Founded
  • MDAI 2013
  • DMA 2011
  • Country
  • MDAI United States
  • DMA United States
  • Employees
  • MDAI N/A
  • DMA N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • DMA Trusts Except Educational Religious and Charitable
  • Sector
  • MDAI Health Care
  • DMA Finance
  • Exchange
  • MDAI Nasdaq
  • DMA Nasdaq
  • Market Cap
  • MDAI 69.0M
  • DMA 78.1M
  • IPO Year
  • MDAI N/A
  • DMA N/A
  • Fundamental
  • Price
  • MDAI $2.44
  • DMA $8.73
  • Analyst Decision
  • MDAI Strong Buy
  • DMA
  • Analyst Count
  • MDAI 2
  • DMA 0
  • Target Price
  • MDAI $4.75
  • DMA N/A
  • AVG Volume (30 Days)
  • MDAI 460.4K
  • DMA 34.6K
  • Earning Date
  • MDAI 08-12-2025
  • DMA 01-01-0001
  • Dividend Yield
  • MDAI N/A
  • DMA 2.04%
  • EPS Growth
  • MDAI N/A
  • DMA N/A
  • EPS
  • MDAI N/A
  • DMA N/A
  • Revenue
  • MDAI $29,962,000.00
  • DMA N/A
  • Revenue This Year
  • MDAI N/A
  • DMA N/A
  • Revenue Next Year
  • MDAI $15.15
  • DMA N/A
  • P/E Ratio
  • MDAI N/A
  • DMA N/A
  • Revenue Growth
  • MDAI 55.21
  • DMA N/A
  • 52 Week Low
  • MDAI $0.82
  • DMA $4.78
  • 52 Week High
  • MDAI $3.25
  • DMA $8.00
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 49.07
  • DMA 54.78
  • Support Level
  • MDAI $2.34
  • DMA $8.72
  • Resistance Level
  • MDAI $2.55
  • DMA $8.89
  • Average True Range (ATR)
  • MDAI 0.17
  • DMA 0.10
  • MACD
  • MDAI -0.04
  • DMA 0.01
  • Stochastic Oscillator
  • MDAI 25.93
  • DMA 63.44

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About DMA Destra Multi-Alternative Fund

Destra Multi-Alternative Fund is a non-diversified, closed-end management investment company that operates as an interval fund with a continuous offering of fund shares. The investment objective of the fund is to seek returns from capital appreciation and income with an emphasis on income generation.

Share on Social Networks: